Iwamoto. Flowmediated release of nitric oxide in isolated, perfused rabbit lungs. J Appl Physiol 91: [363][364][365][366][367][368][369][370] 2001.-The effects of changing perfusate flow on lung nitric oxide (NO) production and pulmonary arterial pressure (Ppa) were tested during normoxia and hypoxia and after N G -monomethyl-L-arginine (L-NMMA) treatment during normoxia in both blood-and buffer-perfused rabbit lungs. Exhaled NO (eNO) was unaltered by changing perfusate flow in blood-perfused lungs. In buffer-perfused lungs, bolus injections of ACh into the pulmonary artery evoked a transient increase in eNO from 67 Ϯ 3 (SE) to 83 Ϯ 7 parts/billion with decrease in Ppa, whereas perfusate NO metabolites (pNOx) remained unchanged.
BLOOD FLOW-DEPENDENT vasodilation has been confirmed in the large conduit arteries of systemic circulation such as femoral (22) and coronary arteries (24) . This response of increased flow is mainly caused by nitric oxide (NO), which is produced by an increase in shear stress of vascular endothelium (6, 17) . In the pulmonary circulation, it has been suggested that NO is released from arterial and venous endothelial cells (12) and contributes to the maintenance of the physiologically low basal pulmonary vascular tone (10, 19, 20) . In addition, the pulmonary vascular bed has a large capacity to adapt to changes in blood flow. However, the role of NO in the mechanism underlying the accommodation to flow changes in the pulmonary circulation is unknown. In humans, it has been demonstrated that changes in pulmonary blood flow with head-out water immersion or increased gravity did not alter exhaled NO output (21) . In contrast, in patients with atrial septal defects, acute changes in pulmonary blood flow with atrial septal defect closure reduced exhaled NO (26) . Controversy remains over the issue of whether exhaled NO reflects endothelial NO production (V NO) under physiological conditions. Furthermore, no direct evidence for flow-induced release of NO has been reported in "in vivo" studies, because NO produced intrinsically in the lung is easily cleared and quickly inactivated by hemoglobin (5) . Therefore, the aim of the present study was to clarify the effects of hemoglobin on lung NO and to determine the role of NO in the mechanism responsible for the adaptability of the pulmonary circulation to changes in blood flow.
Isolated lung perfusion models allow convenient assessment of pulmonary hemodynamics and total V NO by analysis of exhaled NO and perfusate NO metabolites (NOx) during selected experimental conditions (7, 11, 18, 25) . We hypothesized that changes in pulmonary flow would affect both exhaled NO and perfusate NOx during buffer perfusion but not during blood perfusion. In the present study, we measured exhaled NO, perfusate NO metabolites, and pulmonary arterial pressure (Ppa) with stepwise changes in perfusate flow during normoxia (20% O 2 ) and hypoxia (3% O 2 ) and after treatment with N G -monomethyl-L-arginine (L-NMMA), a NO synthase (NOS) inhibitor, during normoxia in buffer-perfused rabbit lungs. In addition, we examined the effect of changing flow on exhaled NO in blood-perfused lungs.
MATERIALS AND METHODS

Preparation of the Isolated Lung Model
The experimental protocol was approved by the Institutional Animal Care and Use Committee of Asahikawa Medical College. Male Japanese albino rabbits weighing between 2.5 and 3.0 kg were anesthetized with pentobarbital sodium (30 mg/kg iv), intubated, and ventilated by a respirator (model 683, Harvard Apparatus) with NO-free room air. The animals underwent cannulation of the right common carotid artery, which was immediately used for heparinization (1,000 U/kg) and phlebotomy (100-150 ml of blood letting). Subsequently, the chest of the animal was opened, and heart and great vessels were exposed. After the main pulmonary artery was cannulated via the apex of the right ventricle and the left atrium via the left ventricle, the lungs with the heart and the trachea were quickly excised en bloc and placed in a humidified chamber kept at 37°C. The isolated lungs were then connected to the circuit, consisting of a roller pump (Master Flex, Cole-Parmer Instrument) and a reservoir, in which circulatory volume was ϳ200 ml. After the lungs were rinsed thoroughly with a buffer solution of Krebs-Henseleit buffer containing (in mM) 119.2 NaCl, 4.7 KCl, 1.2 KH 2PO4, 1.2 MgSO4, 25 NaHCO3, 3.2 CaCl2, and 15 glucose, the perfusion system was closed (buffer-perfused lungs), or, after 150 ml of buffer solution were taken away, autologous blood was added into a reservoir, and hematocrit was adjusted to ϳ15% (blood-perfused lungs). Initially, the pump rate (flow rate) was adjusted to 100 ml/min for stabilization. The pH and PCO 2 of the buffer were adjusted to 7.4 and 40 Torr, respectively, by ventilating the isolated lungs at 0.9 l/min (30 ml of tidal volume ϫ 30 breaths/min) of minute ventilation (V E) with the use of a gas mixture of 20% O2-5% CO2-balance N2 (normoxic gas).
Measurements of Physiological Parameters and Exhaled NO
Ppa and pulmonary venous pressure (Ppv) were measured with pressure transducers (AP-601G, Nihon Koden). Airway pressure (Paw) was also measured with a low-pressure transducer (TP-603T, Nihon Koden). An electromagnetic flowmeter (MFV-1100, Nihon Koden) was placed in line proximal to the pulmonary artery to measure perfusate flow rate. Exhaled NO was continuously measured by a chemiluminescence analyzer (NOA 270B, Sievers) from the outlet limb of the tracheal tube. Signals from these probes were continuously recorded via a data-acquisition system (MacLab, AD Instruments) for real-time recording and later analysis.
A quantitative measurement of exhaled V NO can be obtained by measuring both exhaled NO and V E V NO ͑nl/min͒ ϭ ͓NO͔ ϫ V E where [NO] is the mean concentration of exhaled NO expressed in parts per billion (ppb), and V E is expressed in liters per minute.
Measurements of NOx in the Perfusate
The method for the measurement of NOx [nitrite (NO2 Ϫ ) and nitrate (NO3 Ϫ )] has been previously described in detail (11, 23) . In brief, the perfusate sample was incubated with Aspergillus NO3 Ϫ reductase to reduce NO3 Ϫ to NO2 Ϫ and then acidified using acetoacetate and potassium iodine to convert NO2 Ϫ to NO. The gaseous NO was measured by the chemiluminescence analyzer. In the analyzer, NO combines with ozone to generate a luminescence directly proportional to the amount of NO injected, i.e., to the original NOx in the perfusate sample. Before and after samples were measured, calibration was performed using 1 M of NaNO 2 solution for NO2 Ϫ and NaNO3 solution for NO3 Ϫ , resulting in a perfect linear relationship between actual concentrations and measured values over a wide range (10 Ϫ11 -10 Ϫ9 mol).
Experimental Protocols Protocol 1. Isolated blood-perfused lungs (n ϭ 5) were used to measure levels of exhaled NO at various flow rates. In this protocol, the circuit was closed under normoxic conditions, and the flow rate of perfusate was increased at 25, 50, 75, 100, and 150 ml/min at 4-min intervals.
Protocol 2. Isolated buffer-perfused lungs (n ϭ 6) were used to examine the effect of ACh on Ppa, exhaled NO, and perfusate NOx. To avoid the effect of recirculation of ACh, the lungs were perfused by using an open circuit. During the 20-to 30-min stabilization period, the isolated lungs were perfused with 10 mM of indomethacin to prevent production of prostaglandins. After the stabilization period, the protocol started with perfusion of U-46619 for 15 min, a thromboxane analog (Sigma Chemical) for preconstriction of pulmonary vessels, followed by an opening of the circuit to negate the effect of reperfused ACh. We administered 0.2 ml of 1 M ACh into the pulmonary artery as a bolus, while the exhaled NO and Ppa were continuously measured, and aliquots of the postlung perfusate were sampled at 5-s intervals to measure perfusate NOx concentrations.
Protocol 3. Another group of isolated, buffer-perfused lungs (n ϭ 15) was used to measure levels of exhaled NO and perfusate NOx at various flow rates. In this protocol, the circuit was closed under normoxic conditions, and the flow rate of the perfusate was adjusted to 25, 50, 75, 100, and 150 ml/min at 4-min intervals (normoxia group). In 8 of the 15 lungs, after measurements in normoxia, the ventilating gas was switched to 3% O 2-5% CO2-balance N2 (hypoxic gas), and the same procedure of varying flow rate was repeated (hypoxia group). In the remaining seven lungs, after measurement during normoxia, the same procedure was repeated 30 min after the administration of L-NMMA, a competitive inhibitor of NOS, into the reservoir. The final concentration of L-NMMA in the perfusate was estimated to be 1 ϫ 10 Ϫ4 M (normoxia with L-NMMA group).
During the entire experimental period in each group, the exhaled NO and Ppa were continuously measured, whereas aliquots of the postlung perfusate were sampled at 2-min intervals to measure perfusate NOx accumulation rate, which was calculated from the slope of plots between perfusate NOx concentration and time.
For estimation of pulmonary hemodynamics, the pressureflow relationship was studied. We also calculated pulmonary vascular conductance to examine the effect of hypoxia and
where Q is flow rate of perfusate.
Statistical Analysis
The effect of ACh on exhaled NO and perfusate NOx in protocol 2 was analyzed by an ANOVA with repeated measurements. The difference between data obtained in protocols 1 and 3 was also analyzed by use of an ANOVA. When significance was indicated, a post hoc t-test with Bonferroni's correction for multiple comparisons was used. In all cases, a P value Ͻ 0.05 was considered statistically significant. All data presented represent means Ϯ SE. Figure 1 represents the effect of changing perfusate flow on exhaled NO in a blood-perfused lung. Exhaled NO was unaltered by stepwise increments of perfusate flow. The mean values of exhaled V NO at various flow rates were 28 Ϯ 5 nl/min at 25 ml/min, 27 Ϯ 6 nl/min at 50 ml/min, 26 Ϯ 5 nl/min at 75 ml/min, 25 Ϯ 5 nl/min at 100 ml/min, and 26 Ϯ 6 nl/min at 150 ml/min. There were no statistically significant differences in the mean values of exhaled NO among various flow rates.
RESULTS
Effects of Changing Flow on Exhaled NO in Blood-perfused Lungs
Effects of ACh on Exhaled NO and Perfusate NOx
Administration of ACh into the pulmonary artery increased exhaled NO, whereas it decreased Ppa. Paw was not affected by ACh (Fig. 2) . The mean exhaled NO significantly rose from 67 Ϯ 3 ppb of control value up to 83 Ϯ 7 ppb in 10 s (P Ͻ 0.01), followed by a gradual decrease toward the control level in the next 40 s (Fig.  3 ). Unlike the exhaled NO, which diffused rapidly to the airway, the NOx of the perfusate remained unchanged after ACh (Fig. 3) . The mean Ppa was significantly decreased from 20 Ϯ 2 to 16 Ϯ 2 mmHg after ACh injection (P Ͻ 0.01). Figure 4 illustrates that stepwise elevations of perfusate flow caused corresponding increments of both exhaled NO and Ppa during normoxia. Subsequently, an abrupt reduction in flow elicited a rapid decrease in exhaled NO (Fig. 4A) . Although hypoxia reduced the baseline level of exhaled NO and increased that of Ppa, a flow-dependent increase in exhaled NO was still observed (Fig. 4B) . The administration of L-NMMA into the reservoir caused a rapid fall in exhaled NO and a moderate rise in Ppa (Fig. 5A) . After a stabilization period of ϳ20 min, the stepwise elevations in flow rate did not change exhaled NO but did cause corresponding elevations in Ppa (Fig. 5B) . Figure 6 summarizes the relationship between V NO and flow rate during normoxia and hypoxia and after L-NMMA treatment during normoxia. Stepwise elevations in flow (25, 50, 75, 100, and 150 ml/min) caused corresponding elevations in exhaled V NO (46 Ϯ 2, 59 Ϯ 2, 66 Ϯ 3, 68 Ϯ 4, and 73 Ϯ 3 nl/min, respectively) during normoxia. The V NO rose curvilinearly along with the increase in the perfusate flow during normoxia and hypoxia. However, the administration of L-NMMA elicited a marked drop in V NO and abolished the flow-dependent increase in V NO. In contrast to the exhaled NO responses, no relationship was detected between the perfusate NOx accumulation and flow rate under each experimental condition ( Table 1 ). The level of perfusate NOx accumulation tended to decrease during hypoxia compared with normoxia (hypoxia: 6.3-7.1 (Table 1) . Figure 7 illustrates pressure-flow relationships (Fig.  7A ) and pulmonary vascular conductance-flow curves (Fig. 7B) for the three conditions. In normoxia, there was a linear relationship between Ppa and flow over the range of flows investigated. Hypoxia caused a parallel upward shift in the pressure-flow relationship, and L-NMMA increased the slope of this relation. Pulmonary conductance spontaneously increased progressively along with flow in both normoxia and hypoxia. However, there were no statistically significant differences in conductance after L-NMMA treatment during normoxia among the various flow rates (50, 75, 100, and 150 ml/min). Thus L-NMMA abolished the flowmediated increase in conductance over the range of 50-150 ml/min.
Effects of Changing Flow on Exhaled NO and Perfusate NOx
Effects of Hypoxia and L-NMMA on the Pulmonary Hemodynamics
DISCUSSION
Difference in NO Diffusion Between Buffer-and Blood-perfused Lungs
The major source of lung NO is considered to be the airway epithelium and the pulmonary endothelium, because NOS immunoactivity is localized in both tis- A: L-NMMA caused a rapid fall in exhaled NO with a moderate rise in Ppa at a flow rate of 100 ml/min. B: stepwise increases in flow produced more pronounced elevations in Ppa than those before L-NMMA treatment, whereas exhaled NO remained unchanged.
sues (1, 15) . During blood perfusion, NO produced from the vascular endothelium would be bound by hemoglobin and, therefore, not able to diffuse through the alveoli because of the high affinity of hemoglobin for NO (5) . Furthermore, NO produced from the airway epithelium is continuously cleared into the pulmonary blood via the alveoli during the inspiratory period, whereas the NO remaining in the airway is expired into the exhaled gas (13) . In the present study, we found that the baseline level of exhaled NO in bufferperfused lungs was several times higher than that in blood-perfused lungs, and the flow-mediated changes in exhaled NO observed in buffer-perfused lungs were totally eliminated during blood perfusion. These differences between the two conditions are due to the presence of hemoglobin in the pulmonary circulation. Our basic experimental findings using blood-perfused lungs support previous findings that, in humans, changes in pulmonary blood flow with head-out water immersion or increased gravity failed to alter the output of NO exhaled from the lungs at rest or during exercise (21) . We conclude that exhaled NO does not reflect NO produced from the pulmonary endothelium under physiological conditions of blood perfusion.
During buffer perfusion, because NO is a lipid-soluble and highly diffusible gas (27) , NO produced from the endothelium would either be dissolved into the perfusate to become NOx, or simply diffuse out through the alveoli and appear in the exhaled gas. By measuring these fractions, the kinetics of NO from the endothelium, on stimulation with ACh or changing flow, can be estimated. Therefore, for estimating diffusion kinetics of NO, the lung model with buffer perfusion is of critical importance for determining the role of NO in the regulation of the pulmonary circulation.
Effect of ACh on V NO
ACh causes opposing responses in blood vessels. It stimulates endothelial V NO to result in vasodilation, whereas it constricts vascular smooth muscle by stimulating muscarinic receptors (4). Furthermore, it stimulates the release of vasoconstrictor prostanoids in rabbit lungs (2) . To eliminate the effects of prostanoids in our experiment, we pretreated the perfusate with indomethacin, an inhibitor of cyclooxygenase. A bolus injection of ACh elicited a decrease in Ppa and a transient increase in exhaled NO concentration, whereas perfusate NOx did not change (Figs. 2 and 3) . These results indicate that NO produced from the precapillary arterial endothelium evoked pulmonary vasodilation and then quickly diffused out through the alveoli. This diffusion response of NO is possibly pronounced because NO is a lipid-soluble gas and has a very low buffer-gas partition coefficient (27) . This behavior of NO is consistent with observations of a previous study that showed that NO aerated in the prelung perfusate completely escaped into the exhaled air within a single lung passage, whereas only trace amounts of NO were recovered in the postlung perfusate (25) . Thus a pharmacological stimulus such as ACh can release NO from the endothelium and potentially evoke pulmonary vasodilation. The buffer-perfused lung model reveals the production of endothelial NO as changes in exhaled NO by eliminating the normal in vivo masking effects of hemoglobin.
Effect of Recirculation on Lung NO
Before discussion of the present results, the potential effects of recirculation on the measurement of perfusate NOx and exhaled NO in buffer-perfused lungs should be addressed. As mentioned previously, a fraction of NO produced from the endothelium is dissolved into the well-oxygenated perfusate, after which it is rapidly oxidized to form NO 2 Ϫ and NO 3 Ϫ anions (NOx). These inactive metabolites accumulate in the perfusate by recirculation, and, therefore, the concentration of perfusate NOx increases over time. If the production rate of endothelial NO increases, we can estimate it in part by means of the NOx accumulation rate. The other fraction of NO derived from the endothelium simply diffuses out through alveoli and will be expired in the exhaled gas during a single passage of perfusate through the capillary. It is possible that a small amount of free NO remains in the postlung perfusate without oxidization and that the recirculated free NO could influence measured values of exhaled NO. This possibility, however, seems to be unlikely because, as clearly demonstrated in Fig. 4 , the concentration of exhaled NO rapidly decreased with an abrupt reduction in flow rate. If the recirculated free NO affected values of exhaled NO, the changes in exhaled NO would be delayed after flow reduction. Therefore, it is very unlikely that recirculated free NO influences the measured values of exhaled NO in our preparation. In support of this conclusion, in the present experimental setup, because the circulatory perfusate volume is ϳ200 ml, it would take Ͼ1 min for the postlung perfusate to return to the prelung site, even if flow rate increases up to 150 ml/min. Thus free NO dissolved into the perfusate is either most likely fully oxidized to the inactive form (NOx), after which it returns to the lung, or evaporates from the surface of the reservoir.
Source of Flow-mediated Release of NO
We found that stepwise elevations in flow increased exhaled NO, whereas the perfusate NOx accumulation remained constant (Fig. 6 and Table 1 ). To determine the origin of flow-mediated increments of exhaled NO, we examined the effects of hypoxia, which induces pulmonary vasoconstriction with a decrease in V NO from the airway epithelium (11) , and a NOS antagonist (L-NMMA), which inhibits NO produced from both the airway epithelium and the vascular endothelium.
First, during hypoxia, we observed decreases in exhaled NO with increases in Ppa compared with normoxia. Despite a reduction in the baseline level of exhaled NO during hypoxia, we found that the flowmediated increase in exhaled NO persisted (Fig. 6) , along with the concomitant stepwise increase in pulmonary conductance (Fig. 7) . These findings render it very unlikely that NO derived from the airway epithelium is responsible for the flow-mediated increments of exhaled NO and the flow-mediated increases in pulmonary vascular conductance. Second, we found that L-NMMA greatly diminished the basal production of both exhaled NO (Fig. 6) and perfusate NOx accumulation (Table 1 ) and abolished the flowmediated increase in pulmonary conductance (Fig.  7) . These results suggest that the flow-mediated increase in exhaled NO originates from the vascular endothelium and that this endothelial-derived NO contributes in a major way to the adaptability of the pulmonary circulation to increases in flow. In addition, the source of flow-mediated exhaled NO appears to be the precapillary arterial segment, as opposed to the postcapillary venous segment, because anatomic considerations indicate that only NO produced from the arterial endothelium could contribute to exhaled NO. In support of this view, it has been demonstrated that the major loci of pulmonary vascular resistance are the arterial and precapillary segments and that endothelial NO release from these segments contributes to low resistance of pulmonary circulation (3) .
On the other hand, perfusate NOx accumulation in the steady state has been attributed mainly to the NO produced from the endothelium of both pulmonary arteries and veins (11, 25) . However, if perfusate flow is altered, subsequent changes in perfusate NOx accumulation would likely reflect venous V NO, because most of NO from precapillary endothelium will diffuse out through alveoli as described above. 
Role of NO in Flow-mediated Increase in Conductance
In canine femoral arteries, it has been demonstrated that vessel wall shear stress is involved in flow-mediated vasodilation (24) . NO is considered to be a major mediator of shear stress-induced vasodilation in the systemic resistance vessels (6) . In contrast to the systemic circulation, the pulmonary artery rapidly subdivides into terminal branches that have thinner walls, less smooth muscle, and greater internal diameters than corresponding branches of the systemic arterial tree. These structural properties of the pulmonary vessels offer much less resistance to blood flow than do the systemic arterial vessels. In addition, the pulmonary vascular bed has a regulating system that allows vascular resistance to decrease in response to increased blood flow and/or increases in perfusion pressure (16) . However, the role of NO in the mechanism underlying regulation of the pulmonary circulation in response to increasing flow has not been fully understood. Hakim (8) demonstrated that the reduction in precapillary resistance as flow increased was attenuated after N Gnitro-L-arginine under the condition of pulsatile flow and hypoxia, suggesting that shear stress-induced NO release is present in the pulmonary vascular bed in isolated canine lungs. On the other hand, Cremona et al. (3) reported that N G -nitro-L-arginine did not change the flow-mediated reduction in resistance in pig, suggesting that NO release is not fundamental to the mechanism underlying the flow-mediated decreases in pulmonary vascular resistance. Although we have to consider the differences among animal species in basal release of NO in the lung, to our knowledge, the present study is the first to demonstrate flow-mediated increases in NO release in the pulmonary vascular bed.
Two mechanisms have been postulated to account for the decrease in pulmonary vascular resistance in response to elevated blood flow and perfusion pressure: recruitment and dilation. The term recruitment means that the previously unperfused capillaries are recruited (opened) by the increased flow or perfusion pressure, and the term dilation means that the increased perfusion pressure has dilated those vessels already open (16) . To discuss the role of NO in these flow-mediated hemodynamic changes, the changes in pulmonary vascular conductance (reciprocal of resistance) are illustrated in Fig. 7B . Here, conductance progressively increases along with flow during both normoxia and hypoxia. In our experimental setting, the mean Paw was ϳ6 cmH 2 O, and Ppv ranged from 1 to 2 mmHg (1.3-2.6 cmH 2 O). Under these conditions, it is likely that the perfusion of the isolated lung tends to exhibit the zone II condition in a large part of the lung (9). Thus, under normoxic and hypoxic conditions, increases in conductance in response to elevated flow indicate that the capillary recruitment and/or dilation are occurring along with the increases in flow or perfusion pressure.
In the present study, as clearly demonstrated in Fig.  7 , the administration of L-NMMA abolished the rise in conductance over the range of 50-150 ml/min of flow with a reduction in the lung V NO. With regard to the contribution of NO to this response, we suggest that endothelial NO may be associated with the capillary recruitment and/or shear stress-induced vasodilation. When new parallel pathways for perfusate flow are recruited by the increased flow, NO will be released from the endothelium of the new vessels and contribute to maintaining these vessels open. Similarly, when the increased flow and perfusion pressure distend vessels that are already open, further NO will be released from the endothelium by vascular wall shear stress. Although, from our results, whether either recruitment or shear stress contributes more to flow-mediated increases in exhaled NO is unclear; it has been speculated that recruitment probably occurs with small rises in Ppa, whereas dilation occurs at higher pressures (16) . In the present study, the range of flow rates that we examined was 25-150 ml/min, and the corresponding Ppa range was 4-10 mmHg during normoxia, owing to the buffer-perfused condition (Fig. 7) . Therefore, these relatively low and narrow ranges of pressure may be more likely associated with vascular recruitment contributing to the flow-mediated increases in exhaled NO rather than shear stress.
On the other hand, we hypothesized that the increased flow would elevate perfusate NOx accumulation because capillary recruitment and/or dilation induced by changing flow should increase the venous surface area and shear stress, leading to a release of venous endothelial NO. However, in the range of flow rates examined, we did not observe any changes in perfusate NOx accumulation. Pulmonary veins are distensible because of the thin fibrous wall structure, and they function as a capacitance for the pulmonary circulation (14) . Furthermore, the Ppv is much lower than the arterial pressure. Therefore, in the range of flow rates that we tested, the perfusate might not fully distribute into the widespread capillaries, or the venous pressure might not alter vascular shear stress enough to provoke release of endothelial NO. If flow rates increase severalfold, such as during exercise, perfusate NOx accumulation could conceivably increase. To more precisely define the role of NO in the regulation of the pulmonary circulation in responses to changing flow and pressure, further studies are required.
In summary, we found that the flow-mediated changes in exhaled NO observed in buffer-perfused lungs were totally eliminated in blood-perfused lungs, suggesting that exhaled NO does not reflect NO released from the pulmonary endothelium under physiological conditions of blood perfusion. In the bufferperfused condition, we were able to detect NO release from the endothelium in response to both ACh as a pharmacological stimulus and changing flow as a physiological stimulus. In the present study, the flow-mediated increments of pulmonary conductance, a regulating system of pulmonary circulation in response to increasing flow, were observed with the flow-dependent elevations in exhaled NO under normoxic and hypoxic conditions. L-NMMA abolished this flow-mediated increase in conductance with a reduction in the lung NO, indicating that the endothelial NO may be associated with the capillary recruitment and/or shear stress-induced vasodilation. To more precisely elucidate the role of NO in the flow-mediated increase in conductance, further study will be necessary.
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